STEINMAN LAWRENCE purchased 2.3% of their position (30K shares) of PASITHEA THERAPEUTICS CORP. on the open market
Open‑market purchase worth $12.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/6/2023ACC: 0001493152-23-020333
Director
Since Sep 2021
+30K
Net shares
Net buyer
$12.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
$0.43
Trade value
$12.93K
% of position
2.3%
6/2/2023
1.30M→1.33M
Total
Net shares
+30K
Net value
$12.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2023 | P · Purchase | +30K | $0.43 | $12.93K | 2.3% | 1.30M | 1.33M |
| Total | +30K | $12.93K | ||||||
Derivative Transactions0
No derivative transactions reported